Lupin Foundation bags CRISIL's Highest VO 1A rating for Excellence in Social Responsibility
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
Subscribe To Our Newsletter & Stay Updated